IBDEI0WT ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,14789,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,14789,1,3,0)
;;=3^Aphasia after non-traumatic SAH
;;^UTILITY(U,$J,358.3,14789,1,4,0)
;;=4^I69.020
;;^UTILITY(U,$J,358.3,14789,2)
;;=^5007395
;;^UTILITY(U,$J,358.3,14790,0)
;;=I69.120^^58^707^3
;;^UTILITY(U,$J,358.3,14790,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,14790,1,3,0)
;;=3^Aphasia after non-traumatic ICH
;;^UTILITY(U,$J,358.3,14790,1,4,0)
;;=4^I69.120
;;^UTILITY(U,$J,358.3,14790,2)
;;=^5007427
;;^UTILITY(U,$J,358.3,14791,0)
;;=I69.320^^58^707^2
;;^UTILITY(U,$J,358.3,14791,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,14791,1,3,0)
;;=3^Aphasia after cerebral infarction
;;^UTILITY(U,$J,358.3,14791,1,4,0)
;;=4^I69.320
;;^UTILITY(U,$J,358.3,14791,2)
;;=^5007491
;;^UTILITY(U,$J,358.3,14792,0)
;;=I69.091^^58^707^9
;;^UTILITY(U,$J,358.3,14792,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,14792,1,3,0)
;;=3^Dysphagia after non-traumatic SAH
;;^UTILITY(U,$J,358.3,14792,1,4,0)
;;=4^I69.091
;;^UTILITY(U,$J,358.3,14792,2)
;;=^5007421
;;^UTILITY(U,$J,358.3,14793,0)
;;=I69.191^^58^707^8
;;^UTILITY(U,$J,358.3,14793,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,14793,1,3,0)
;;=3^Dysphagia after non-traumatic ICH
;;^UTILITY(U,$J,358.3,14793,1,4,0)
;;=4^I69.191
;;^UTILITY(U,$J,358.3,14793,2)
;;=^5007453
;;^UTILITY(U,$J,358.3,14794,0)
;;=I69.391^^58^707^7
;;^UTILITY(U,$J,358.3,14794,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,14794,1,3,0)
;;=3^Dysphagia after cerebral infaction
;;^UTILITY(U,$J,358.3,14794,1,4,0)
;;=4^I69.391
;;^UTILITY(U,$J,358.3,14794,2)
;;=^5007516
;;^UTILITY(U,$J,358.3,14795,0)
;;=I69.351^^58^707^16
;;^UTILITY(U,$J,358.3,14795,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,14795,1,3,0)
;;=3^Hemiplegia after CVA-Rt dominant side
;;^UTILITY(U,$J,358.3,14795,1,4,0)
;;=4^I69.351
;;^UTILITY(U,$J,358.3,14795,2)
;;=^5007504
;;^UTILITY(U,$J,358.3,14796,0)
;;=I69.352^^58^707^14
;;^UTILITY(U,$J,358.3,14796,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,14796,1,3,0)
;;=3^Hemiplegia after CVA-Lt dominant side
;;^UTILITY(U,$J,358.3,14796,1,4,0)
;;=4^I69.352
;;^UTILITY(U,$J,358.3,14796,2)
;;=^5007505
;;^UTILITY(U,$J,358.3,14797,0)
;;=I69.353^^58^707^17
;;^UTILITY(U,$J,358.3,14797,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,14797,1,3,0)
;;=3^Hemiplegia after CVA-Rt non-dominant side
;;^UTILITY(U,$J,358.3,14797,1,4,0)
;;=4^I69.353
;;^UTILITY(U,$J,358.3,14797,2)
;;=^5007506
;;^UTILITY(U,$J,358.3,14798,0)
;;=I69.354^^58^707^15
;;^UTILITY(U,$J,358.3,14798,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,14798,1,3,0)
;;=3^Hemiplegia after CVA-Lt non-dominant side
;;^UTILITY(U,$J,358.3,14798,1,4,0)
;;=4^I69.354
;;^UTILITY(U,$J,358.3,14798,2)
;;=^5007507
;;^UTILITY(U,$J,358.3,14799,0)
;;=I69.331^^58^707^40
;;^UTILITY(U,$J,358.3,14799,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,14799,1,3,0)
;;=3^Monoplegia Upper Limb after CVA-Rt Dominant Side
;;^UTILITY(U,$J,358.3,14799,1,4,0)
;;=4^I69.331
;;^UTILITY(U,$J,358.3,14799,2)
;;=^5007496
;;^UTILITY(U,$J,358.3,14800,0)
;;=I69.332^^58^707^38
;;^UTILITY(U,$J,358.3,14800,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,14800,1,3,0)
;;=3^Monoplegia Upper Limb after CVA-Lt Dominant Side
;;^UTILITY(U,$J,358.3,14800,1,4,0)
;;=4^I69.332
;;^UTILITY(U,$J,358.3,14800,2)
;;=^5007497
;;^UTILITY(U,$J,358.3,14801,0)
;;=I69.333^^58^707^41
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0WT 3758 printed Apr 09, 2024@20:49:22 Page 2
IBDEI0WT ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,14789,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,14789,1,3,0)
+4 ;;=3^Aphasia after non-traumatic SAH
+5 ;;^UTILITY(U,$J,358.3,14789,1,4,0)
+6 ;;=4^I69.020
+7 ;;^UTILITY(U,$J,358.3,14789,2)
+8 ;;=^5007395
+9 ;;^UTILITY(U,$J,358.3,14790,0)
+10 ;;=I69.120^^58^707^3
+11 ;;^UTILITY(U,$J,358.3,14790,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,14790,1,3,0)
+14 ;;=3^Aphasia after non-traumatic ICH
+15 ;;^UTILITY(U,$J,358.3,14790,1,4,0)
+16 ;;=4^I69.120
+17 ;;^UTILITY(U,$J,358.3,14790,2)
+18 ;;=^5007427
+19 ;;^UTILITY(U,$J,358.3,14791,0)
+20 ;;=I69.320^^58^707^2
+21 ;;^UTILITY(U,$J,358.3,14791,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,14791,1,3,0)
+24 ;;=3^Aphasia after cerebral infarction
+25 ;;^UTILITY(U,$J,358.3,14791,1,4,0)
+26 ;;=4^I69.320
+27 ;;^UTILITY(U,$J,358.3,14791,2)
+28 ;;=^5007491
+29 ;;^UTILITY(U,$J,358.3,14792,0)
+30 ;;=I69.091^^58^707^9
+31 ;;^UTILITY(U,$J,358.3,14792,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,14792,1,3,0)
+34 ;;=3^Dysphagia after non-traumatic SAH
+35 ;;^UTILITY(U,$J,358.3,14792,1,4,0)
+36 ;;=4^I69.091
+37 ;;^UTILITY(U,$J,358.3,14792,2)
+38 ;;=^5007421
+39 ;;^UTILITY(U,$J,358.3,14793,0)
+40 ;;=I69.191^^58^707^8
+41 ;;^UTILITY(U,$J,358.3,14793,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,14793,1,3,0)
+44 ;;=3^Dysphagia after non-traumatic ICH
+45 ;;^UTILITY(U,$J,358.3,14793,1,4,0)
+46 ;;=4^I69.191
+47 ;;^UTILITY(U,$J,358.3,14793,2)
+48 ;;=^5007453
+49 ;;^UTILITY(U,$J,358.3,14794,0)
+50 ;;=I69.391^^58^707^7
+51 ;;^UTILITY(U,$J,358.3,14794,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,14794,1,3,0)
+54 ;;=3^Dysphagia after cerebral infaction
+55 ;;^UTILITY(U,$J,358.3,14794,1,4,0)
+56 ;;=4^I69.391
+57 ;;^UTILITY(U,$J,358.3,14794,2)
+58 ;;=^5007516
+59 ;;^UTILITY(U,$J,358.3,14795,0)
+60 ;;=I69.351^^58^707^16
+61 ;;^UTILITY(U,$J,358.3,14795,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,14795,1,3,0)
+64 ;;=3^Hemiplegia after CVA-Rt dominant side
+65 ;;^UTILITY(U,$J,358.3,14795,1,4,0)
+66 ;;=4^I69.351
+67 ;;^UTILITY(U,$J,358.3,14795,2)
+68 ;;=^5007504
+69 ;;^UTILITY(U,$J,358.3,14796,0)
+70 ;;=I69.352^^58^707^14
+71 ;;^UTILITY(U,$J,358.3,14796,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,14796,1,3,0)
+74 ;;=3^Hemiplegia after CVA-Lt dominant side
+75 ;;^UTILITY(U,$J,358.3,14796,1,4,0)
+76 ;;=4^I69.352
+77 ;;^UTILITY(U,$J,358.3,14796,2)
+78 ;;=^5007505
+79 ;;^UTILITY(U,$J,358.3,14797,0)
+80 ;;=I69.353^^58^707^17
+81 ;;^UTILITY(U,$J,358.3,14797,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,14797,1,3,0)
+84 ;;=3^Hemiplegia after CVA-Rt non-dominant side
+85 ;;^UTILITY(U,$J,358.3,14797,1,4,0)
+86 ;;=4^I69.353
+87 ;;^UTILITY(U,$J,358.3,14797,2)
+88 ;;=^5007506
+89 ;;^UTILITY(U,$J,358.3,14798,0)
+90 ;;=I69.354^^58^707^15
+91 ;;^UTILITY(U,$J,358.3,14798,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,14798,1,3,0)
+94 ;;=3^Hemiplegia after CVA-Lt non-dominant side
+95 ;;^UTILITY(U,$J,358.3,14798,1,4,0)
+96 ;;=4^I69.354
+97 ;;^UTILITY(U,$J,358.3,14798,2)
+98 ;;=^5007507
+99 ;;^UTILITY(U,$J,358.3,14799,0)
+100 ;;=I69.331^^58^707^40
+101 ;;^UTILITY(U,$J,358.3,14799,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,14799,1,3,0)
+104 ;;=3^Monoplegia Upper Limb after CVA-Rt Dominant Side
+105 ;;^UTILITY(U,$J,358.3,14799,1,4,0)
+106 ;;=4^I69.331
+107 ;;^UTILITY(U,$J,358.3,14799,2)
+108 ;;=^5007496
+109 ;;^UTILITY(U,$J,358.3,14800,0)
+110 ;;=I69.332^^58^707^38
+111 ;;^UTILITY(U,$J,358.3,14800,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,14800,1,3,0)
+114 ;;=3^Monoplegia Upper Limb after CVA-Lt Dominant Side
+115 ;;^UTILITY(U,$J,358.3,14800,1,4,0)
+116 ;;=4^I69.332
+117 ;;^UTILITY(U,$J,358.3,14800,2)
+118 ;;=^5007497
+119 ;;^UTILITY(U,$J,358.3,14801,0)
+120 ;;=I69.333^^58^707^41
